Market Overview

According to MarketGenics, the global Neurodegenerative Disorders Market was valued at USD 39.8 billion in 2025 and is projected to reach USD 69.9 billion by 2035, registering a CAGR of 5.8% during the forecast period of 2026–2035. The market is witnessing steady growth due to the increasing prevalence of neurological conditions, including Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis (ALS), and multiple sclerosis. Neurodegenerative disorders are characterized by the progressive deterioration of nerve cells, affecting memory, movement, cognitive abilities, and overall neurological functioning. The growing demand for effective treatment options, early diagnosis, and disease-management solutions is encouraging pharmaceutical and biotechnology companies to invest in advanced therapeutic development. Increasing research into disease-modifying treatments, biologics, gene therapies, and precision medicine is further supporting innovation across the neurodegenerative disorders market. Alzheimer's disease represents a major segment, accounting for approximately 45% of the global market in 2025, supported by its high prevalence and significant unmet medical needs.

To obtain a free sample research report - https://marketgenics.co/download-report-sample/neurodegenerative-disorders-market-59115

Market Growth Drivers

The Neurodegenerative Disorders Market is primarily driven by the rising global aging population, increasing prevalence of neurological diseases, and growing demand for advanced treatment options. As life expectancy increases, the number of individuals affected by Alzheimer's disease, Parkinson's disease, and other age-associated neurological conditions is also rising, creating greater demand for effective diagnosis and treatment. Continuous advancements in neuroscience research, molecular diagnostics, biomarker identification, and drug discovery are helping pharmaceutical companies develop innovative therapies targeting underlying disease mechanisms. The growing adoption of disease-modifying treatments, monoclonal antibodies, gene-based therapies, and other advanced therapeutic approaches is creating new opportunities for market expansion. Additionally, increasing investments in clinical trials, collaborations between pharmaceutical companies and research institutions, and government-supported neurological research programs are accelerating drug development. Improvements in diagnostic imaging, genetic testing, and early disease detection are also supporting timely intervention and better disease management.

Regional Insights

North America holds a leading position in the Neurodegenerative Disorders Market, supported by advanced healthcare infrastructure, significant pharmaceutical research and development investments, established biotechnology companies, and access to innovative neurological treatments. The United States represents a major contributor due to its strong clinical research ecosystem and increasing adoption of advanced therapies for Alzheimer's disease, Parkinson's disease, and other neurological conditions. Europe is another important market, driven by growing investments in neuroscience research, expanding clinical trial activities, and increasing awareness of early diagnosis and disease management across countries such as Germany, the United Kingdom, and France. Meanwhile, Asia-Pacific is expected to be the fastest-growing regional market, supported by its rapidly aging population, expanding healthcare investments, improving access to neurological treatments, and growing pharmaceutical research capabilities. Countries including China, India, Japan, South Korea, and Australia are creating opportunities through healthcare infrastructure development, clinical research expansion, and increasing awareness of neurological disorders. The Middle East, Africa, and South America are also gradually strengthening their healthcare systems and diagnostic capabilities, creating further opportunities for neurodegenerative disease treatment and management.

Related Reports:

Embedded Finance Market

Edge Computing Market

Digital Product Passport Solutions Market

Deepfake Detection Technology Market

Decentralized Identity Solutions Market

Contact:
Mr. Debashish Roy
MarketGenics Global Research
800 N King Street, Suite 304 #4208, Wilmington, DE 19801, United States
USA: +1 (302) 303-2617
Email: sales@marketgenics.co